Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|May 5, 2005
Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancerI Songun, S V Litvinov, C J H van de Velde, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 1, 1997
Markers for assessment of nodal metastasis in laryngeal carcinomaR P Takes, R J Baatenburg de Jong, E Schuuring, et al.
The American Journal of Pathology|March 1, 1996
Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiationS V Litvinov, W van Driel, C M van Rhijn, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patientsR M Luiten, S O Warnaar, D Sanborn, et al.
Human Molecular Genetics|November 7, 2000
Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cellsM S Scheffers, P van der Bent, F Prins, et al.
Toxicology and Applied Pharmacology|August 18, 2001
Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicityB T Leussink, S V Litvinov, E de Heer, et al.
The Journal of Cell Biology|January 7, 1998
Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherinsS V Litvinov, M Balzar, M J Winter, et al.
The American Journal of Pathology|August 6, 1999
Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervixC J de Boer, E van Dorst, H van Krieken, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumoursS von Mensdorff-Pouilly, M M Gourevitch, P Kenemans, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1996
The role of monoclonal antibody affinity in tumor immunotherapy evaluated in in vivo models for minimal residual diseaseM P Velders, C M van Rhijn, I M Cornelissen, et al.
Pageof 6